Gillanders et al., by analyzing 49 Australian families with familial melanoma and no mutations in CDKN2A and CDK4 genes, identified a novel melanoma susceptibility locus on Chr1p22, confirmed by the further analysis of other families from other countries [89]. This evidence concerns the gene CDK4 and melanoma.